WT
VRTX icon

Washington Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Washington Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Hold
537
– – 0.01% 265
2026
Q1 		$240K Sell
537
-197
-27% -$91.9K 0.01% 262
2025
Q4 		$333K Buy
734
+6
+0.8% +$2.59K 0.01% 231
2025
Q3 		$285K Buy
+728
New +$304K 0.01% 244
2025
Q2 		– Sell
-98
Closed -$47.5K – 715
2025
Q1 		$47.5K Sell
98
-600
-86% -$280K ﹤0.01% 417
2024
Q4 		$281K Sell
698
-103
-13% -$47.7K 0.01% 243
2024
Q3 		$373K Hold
801
– – 0.01% 226
2024
Q2 		$375K Buy
801
+67
+9% +$29.1K 0.01% 223
2024
Q1 		$307K Buy
734
+43
+6% +$18.2K 0.01% 241
2023
Q4 		$281K Buy
691
+60
+10% +$22.2K 0.01% 238
2023
Q3 		$219K Hold
631
– – 0.01% 237
2023
Q2 		$222K Buy
631
+9
+1% +$3.03K 0.01% 246
2023
Q1 		$196K Hold
622
– – 0.01% 253
2022
Q4 		$180K Hold
622
– – 0.01% 260
2022
Q3 		$180K Buy
622
+300
+93% +$86.3K 0.01% 248
2022
Q2 		$91K Hold
322
– – ﹤0.01% 321
2022
Q1 		$84K Buy
322
+303
+1,595% +$71.9K ﹤0.01% 356
2021
Q4 		$4K Sell
19
-5
-21% -$972 ﹤0.01% 774
2021
Q3 		$4K Buy
24
+5
+26% +$976 ﹤0.01% 891
2021
Q2 		$4K Sell
19
-4
-17% -$837 ﹤0.01% 892
2021
Q1 		$5K Buy
23
+2
+10% +$439 ﹤0.01% 829
2020
Q4 		$5K Hold
21
– – ﹤0.01% 808
2020
Q3 		$6K Buy
21
+5
+31% +$1.38K ﹤0.01% 783
2020
Q2 		$5K Hold
16
– – ﹤0.01% 715
2020
Q1 		$4K Buy
+16
New +$3.67K ﹤0.01% 787
2018
Q3 		– Sell
-13
Closed -$2K – 799
2018
Q2 		$2K Buy
+13
New +$2.02K ﹤0.01% 830

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Washington Trust's VRTX Position: Q2 2026 in Review

Washington Trust held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 537 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #265.

Washington Trust first reported a position in VRTX in Q2 2018 and has held it in 26 quarters since. The position peaked at $375K in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Washington Trust held 537 shares of Vertex Pharmaceuticals worth $267K as of Q2 2026.
  • Washington Trust left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Washington Trust's portfolio in Q2 2026, its #265 holding.
  • Washington Trust first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 26 quarters since.
  • Washington Trust's Vertex Pharmaceuticals position peaked at $375K in Q2 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Washington Trust's 13F filing for Q2 2026, filed 3 Aug 2026.